Cargando…
Mesenchymal Stem Cell Therapy for Aging Frailty
Chronic diseases and degenerative conditions are strongly linked with the geriatric syndrome of frailty and account for a disproportionate percentage of the health care budget. Frailty increases the risk of falls, hospitalization, institutionalization, disability, and death. By definition, frailty s...
Autores principales: | Schulman, Ivonne Hernandez, Balkan, Wayne, Hare, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249304/ https://www.ncbi.nlm.nih.gov/pubmed/30498696 http://dx.doi.org/10.3389/fnut.2018.00108 |
Ejemplares similares
-
Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
por: Premer, Courtney, et al.
Publicado: (2019) -
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
por: Premer, Courtney, et al.
Publicado: (2015) -
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
por: Golpanian, Samuel, et al.
Publicado: (2017) -
Perspectives on the Evolution of Stem Cell Therapy for Heart Failure
por: Tompkins, Bryon, et al.
Publicado: (2015) -
Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty
por: Golpanian, Samuel, et al.
Publicado: (2016)